Cue Biopharma, Inc., 2026-05-14
An SEC Form D private-offering notice from Boston, MA, a $29,999,992 filer-stated offering target in Biotech. Filed 2026-05-14. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Publicly traded (NASDAQ: CUE) clinical-stage biopharmaceutical company developing engineered immuno-oncology and immunology biologics via its Immuno-STAT platform
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Remedium Bio Inc., 2026-05-18, $10M, Needham, MA
- Trellis Bioscience, Inc., 2026-05-15, Redwood City, CA
- Data Management & Compliance, Inc. DBA Warchest, 2026-05-15, $3.5M, Lexington, MA
- Gaius Therapeutics, Inc,, 2026-05-14, $250K, San Diego, CA
- Blitzy, Inc., 2026-05-15, $190M, Cambridge, MA
- EtiraRX, Inc., 2026-05-14, $3M, Dallas, TX
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.